Literature DB >> 30056625

Rhabdomyolysis observed at forensic autopsy: a series of 52 cases.

Hsuan-Yun Hu1, Shyh-Yuh Wei1,2, Chih-Hsin Pan3.   

Abstract

Rhabdomyolysis is characterized by skeletal muscle injury resulting in the release of intracellular proteins (such as myoglobin) and electrolytes into the blood circulation, which cause acute kidney injury, myoglobinuria and electrolyte imbalances. Clinical diagnosis of rhabdomyolysis is made on the basis of biochemical analysis; however, for forensic autopsies, biochemical data are often not available, and it is necessary to diagnose rhabdomyolysis via histopathological examinations. This study analyzed 52 cases with rhabdomyolysis and applied myoglobin immunohistochemistry to kidney, urine and blood samples. We found that blunt force injuries were the most common cause of rhabdomyolysis across all age groups, and drugs were the second most common cause. The drugs included ketamines, amphetamines, synthetic cathinones, entheogens, benzodiazepines, opioid analgesics, and anesthesia. Less than 60% of our cases had biochemical data, including myoglobin (92.5~416,978 ng/mL), creatine kinase (220~774,015 U/L), potassium (1.6~10.3 meq/L), calcium (2.7~29.2 mg/dL), and phosphorus (2.6~14.2 mg/dL). In the kidney tissue sections, we found that 95% of the rhabdomyolysis cases were positive for myoglobin immunohistochemistry and that 96% were associated with acute tubular necrosis. Our findings describe the features of fatal rhabdomyolysis in a large series and suggest that myoglobin immunohistochemistry can be used in post-mortem blood and urine cell blocks to detect myoglobin.

Entities:  

Keywords:  Cytology; Forensic autopsy; Immunohistochemistry; Myoglobin; Rhabdomyolysis

Mesh:

Substances:

Year:  2018        PMID: 30056625     DOI: 10.1007/s12024-018-0003-x

Source DB:  PubMed          Journal:  Forensic Sci Med Pathol        ISSN: 1547-769X            Impact factor:   2.007


  15 in total

Review 1.  Unmasking the Janus face of myoglobin in health and disease.

Authors:  U B Hendgen-Cotta; U Flögel; M Kelm; T Rassaf
Journal:  J Exp Biol       Date:  2010-08-15       Impact factor: 3.312

2.  Rhabdomyolysis. The role of diagnostic and prognostic factors.

Authors:  Eran Keltz; Fahmi Yousef Khan; Gideon Mann
Journal:  Muscles Ligaments Tendons J       Date:  2014-02-24

Review 3.  Rhabdomyolysis.

Authors:  Janice L Zimmerman; Michael C Shen
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

4.  Post-mortem urinary myoglobin levels with reference to the causes of death.

Authors:  B L Zhu; K Ishida; L Quan; M Taniguchi; S Oritani; Y Kamikodai; M Q Fujita; H Maeda
Journal:  Forensic Sci Int       Date:  2001-01-15       Impact factor: 2.395

Review 5.  Rhabdomyolysis.

Authors:  John M Sauret; George Marinides; Gordon K Wang
Journal:  Am Fam Physician       Date:  2002-03-01       Impact factor: 3.292

Review 6.  Rhabdomyolysis: review of the literature.

Authors:  R Zutt; A J van der Kooi; G E Linthorst; R J A Wanders; M de Visser
Journal:  Neuromuscul Disord       Date:  2014-05-21       Impact factor: 4.296

Review 7.  Mechanisms of rhabdomyolysis.

Authors:  J P Knochel
Journal:  Curr Opin Rheumatol       Date:  1993-11       Impact factor: 5.006

Review 8.  [Rhabdomyolysis].

Authors:  M G Mohaupt
Journal:  Ther Umsch       Date:  2003-07

Review 9.  Nephrotoxic effects of designer drugs: synthetic is not better!

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2014-03-25       Impact factor: 28.314

Review 10.  Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.

Authors:  Ana L Huerta-Alardín; Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2004-10-20       Impact factor: 9.097

View more
  1 in total

Review 1.  Evaluation of the distribution of nicotine intravenous injection: an adult autopsy case report with a review of literature.

Authors:  Yayoi Aoki; Tomoya Ikeda; Naoto Tani; Alissa Shida; Shigeki Oritani; Takaki Ishikawa
Journal:  Int J Legal Med       Date:  2019-04-07       Impact factor: 2.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.